Avanos Historical Income Statement

AVNS Stock

USD 18.10 0.25 1.40%

Historical analysis of Avanos Medical income statement accounts such as Interest Expense of 16.1 M, Selling General Administrative of 286.2 M or Total Revenue of 909.2 M can show how well Avanos Medical performed in making a profits. Evaluating Avanos Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Avanos Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Avanos Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Avanos Medical is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avanos Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.

About Avanos Income Statement Analysis

Avanos Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Avanos Medical shareholders. The income statement also shows Avanos investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Avanos Medical Income Statement Chart

Avanos Medical Income Statement is one of the three primary financial statements used for reporting Avanos's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Avanos Medical revenue and expense. Avanos Medical Income Statement primarily focuses on the company's revenues and expenses during a particular period.

At this time, Avanos Medical's Discontinued Operations is comparatively stable compared to the past year. Non Operating Income Net Other is likely to gain to about 2.1 M in 2024, whereas Selling General Administrative is likely to drop slightly above 286.2 M in 2024.

Interest Expense Selling General Administrative Total Revenue Gross Profit Other Operating Expenses Income Tax Expense

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Total Revenue

Total revenue comprises all receipts Avanos Medical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Avanos Medical minus its cost of goods sold. It is profit before Avanos Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Avanos Medical. It is also known as Avanos Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Avanos Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Avanos Medical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avanos Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.At this time, Avanos Medical's Discontinued Operations is comparatively stable compared to the past year. Non Operating Income Net Other is likely to gain to about 2.1 M in 2024, whereas Selling General Administrative is likely to drop slightly above 286.2 M in 2024.

	2021	2022	2024 (projected)
Interest Expense	3.3M	10M	16.1M
Depreciation And Amortization	38.5M	48.9M	43.6M

Interest Expense Depreciation And Amortization

Avanos Medical income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Discontinued Operations	Net Income From Continuing Ops	Non Operating Income Net Other	Tax Provision	Interest Income	Non Recurring	Extraordinary Items	Net Interest Income	Reconciled Depreciation	Selling And Marketing Expenses
Depreciation And Amortization		-0.01	0.65	0.7	0.61	0.74	0.09	0.41	0.12	0.51	0.71	0.49	0.1	-0.18	-0.02	0.5	-0.57	-0.09	-0.27	-0.53	0.56	0.26	-0.57	-0.73	0.79	0.26
Interest Expense	-0.01		0.19	-0.34	-0.42	-0.27	-0.72	-0.58	0.43	-0.55	-0.32	0.33	-0.76	-0.51	-0.57	-0.68	0.52	-0.55	-0.02	0.37	-0.46	-0.06	0.52	-0.02	-0.11	-0.06
Selling General Administrative	0.65	0.19		0.51	0.51	0.58	-0.15	0.13	0.37	0.2	0.5	0.89	-0.13	-0.24	-0.22	0.27	-0.35	-0.2	0.13	-0.28	0.38	0.48	-0.36	-0.47	0.46	0.48
Total Revenue	0.7	-0.34	0.51		0.97	0.99	0.37	0.86	-0.03	0.9	1.0	0.31	0.4	-0.14	0.15	0.88	-0.85	0.04	-0.18	-0.67	0.85	0.26	-0.85	-0.82	0.78	0.26
Gross Profit	0.61	-0.42	0.51	0.97		0.94	0.48	0.9	0.02	0.93	0.95	0.29	0.5	-0.04	0.26	0.91	-0.84	0.14	-0.07	-0.63	0.83	0.35	-0.84	-0.77	0.75	0.35
Other Operating Expenses	0.74	-0.27	0.58	0.99	0.94		0.3	0.79	0.03	0.84	0.99	0.41	0.32	-0.18	0.09	0.82	-0.82	-0.01	-0.18	-0.66	0.82	0.29	-0.83	-0.83	0.78	0.29
Operating Income	0.09	-0.72	-0.15	0.37	0.48	0.3		0.62	-0.06	0.59	0.34	-0.27	1.0	0.8	0.91	0.65	-0.28	0.88	0.14	-0.15	0.27	0.03	-0.28	-0.23	0.25	0.03
Ebit	0.41	-0.58	0.13	0.86	0.9	0.79	0.62		-0.24	0.99	0.84	-0.15	0.63	0.04	0.37	0.95	-0.81	0.24	-0.13	-0.58	0.8	0.1	-0.82	-0.65	0.65	0.1
Research Development	0.12	0.43	0.37	-0.03	0.02	0.03	-0.06	-0.24		-0.21	-0.04	0.61	-0.04	0.16	0.2	-0.22	0.19	0.01	0.48	0.02	-0.13	0.55	0.19	-0.25	0.04	0.55
Ebitda	0.51	-0.55	0.2	0.9	0.93	0.84	0.59	0.99	-0.21		0.88	-0.07	0.61	0.01	0.35	0.96	-0.84	0.21	-0.15	-0.61	0.83	0.12	-0.84	-0.71	0.71	0.12
Cost Of Revenue	0.71	-0.32	0.5	1.0	0.95	0.99	0.34	0.84	-0.04	0.88		0.31	0.37	-0.17	0.12	0.86	-0.84	0.02	-0.2	-0.67	0.84	0.23	-0.85	-0.82	0.78	0.23
Total Operating Expenses	0.49	0.33	0.89	0.31	0.29	0.41	-0.27	-0.15	0.61	-0.07	0.31		-0.23	-0.16	-0.21	-0.01	-0.12	-0.21	0.16	-0.18	0.15	0.6	-0.13	-0.34	0.29	0.6
Income Before Tax	0.1	-0.76	-0.13	0.4	0.5	0.32	1.0	0.63	-0.04	0.61	0.37	-0.23		0.8	0.92	0.67	-0.32	0.86	0.16	-0.2	0.31	0.09	-0.32	-0.25	0.26	0.09
Total Other Income Expense Net	-0.18	-0.51	-0.24	-0.14	-0.04	-0.18	0.8	0.04	0.16	0.01	-0.17	-0.16	0.8		0.9	0.13	0.21	0.92	0.31	0.19	-0.22	0.05	0.21	0.18	-0.15	0.05
Net Income	-0.02	-0.57	-0.22	0.15	0.26	0.09	0.91	0.37	0.2	0.35	0.12	-0.21	0.92	0.9		0.4	-0.09	0.85	0.29	-0.1	0.09	0.2	-0.09	-0.17	0.17	0.2
Income Tax Expense	0.5	-0.68	0.27	0.88	0.91	0.82	0.65	0.95	-0.22	0.96	0.86	-0.01	0.67	0.13	0.4		-0.86	0.3	-0.03	-0.62	0.85	0.17	-0.87	-0.61	0.61	0.17
Discontinued Operations	-0.57	0.52	-0.35	-0.85	-0.84	-0.82	-0.28	-0.81	0.19	-0.84	-0.84	-0.12	-0.32	0.21	-0.09	-0.86		0.14	0.01	0.9	-0.99	-0.3	1.0	0.71	-0.67	-0.3
Net Income From Continuing Ops	-0.09	-0.55	-0.2	0.04	0.14	-0.01	0.88	0.24	0.01	0.21	0.02	-0.21	0.86	0.92	0.85	0.3	0.14		0.1	0.26	-0.16	-0.06	0.14	0.11	-0.07	-0.06
Non Operating Income Net Other	-0.27	-0.02	0.13	-0.18	-0.07	-0.18	0.14	-0.13	0.48	-0.15	-0.2	0.16	0.16	0.31	0.29	-0.03	0.01	0.1		-0.1	0.09	0.14	0.01	0.02	-0.34	0.14
Tax Provision	-0.53	0.37	-0.28	-0.67	-0.63	-0.66	-0.15	-0.58	0.02	-0.61	-0.67	-0.18	-0.2	0.19	-0.1	-0.62	0.9	0.26	-0.1		-0.9	-0.38	0.89	0.73	-0.66	-0.38
Interest Income	0.56	-0.46	0.38	0.85	0.83	0.82	0.27	0.8	-0.13	0.83	0.84	0.15	0.31	-0.22	0.09	0.85	-0.99	-0.16	0.09	-0.9		0.27	-0.99	-0.74	0.65	0.27
Non Recurring	0.26	-0.06	0.48	0.26	0.35	0.29	0.03	0.1	0.55	0.12	0.23	0.6	0.09	0.05	0.2	0.17	-0.3	-0.06	0.14	-0.38	0.27		-0.3	-0.33	0.42	1.0
Extraordinary Items	-0.57	0.52	-0.36	-0.85	-0.84	-0.83	-0.28	-0.82	0.19	-0.84	-0.85	-0.13	-0.32	0.21	-0.09	-0.87	1.0	0.14	0.01	0.89	-0.99	-0.3		0.71	-0.67	-0.3
Net Interest Income	-0.73	-0.02	-0.47	-0.82	-0.77	-0.83	-0.23	-0.65	-0.25	-0.71	-0.82	-0.34	-0.25	0.18	-0.17	-0.61	0.71	0.11	0.02	0.73	-0.74	-0.33	0.71		-0.87	-0.33
Reconciled Depreciation	0.79	-0.11	0.46	0.78	0.75	0.78	0.25	0.65	0.04	0.71	0.78	0.29	0.26	-0.15	0.17	0.61	-0.67	-0.07	-0.34	-0.66	0.65	0.42	-0.67	-0.87		0.42
Selling And Marketing Expenses	0.26	-0.06	0.48	0.26	0.35	0.29	0.03	0.1	0.55	0.12	0.23	0.6	0.09	0.05	0.2	0.17	-0.3	-0.06	0.14	-0.38	0.27	1.0	-0.3	-0.33	0.42

Click cells to compare fundamentals

Avanos Medical Account Relationship Matchups

Avanos Medical income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	43.6M	44.1M	38.5M	48.9M	46.1M	43.6M
Interest Expense	26.4M	15M	15.6M	3.3M	10M	16.1M
Selling General Administrative	399.1M	332.6M	300.3M	341.9M	335M	286.2M
Total Revenue	697.6M	714.8M	744.6M	820M	673.3M	909.2M
Gross Profit	402.2M	373.3M	364.3M	450M	382.7M	378.1M
Other Operating Expenses	753.3M	760.9M	735.7M	746M	620.9M	851.8M
Operating Income	(55.7M)	(46.1M)	8.9M	74M	52.4M	28.2M
Ebit	(55.7M)	(46.1M)	8.9M	74M	52.4M	58.8M
Research Development	41.8M	37.7M	34.9M	30.6M	27.2M	27.8M
Ebitda	(12.1M)	(2M)	47.4M	122.9M	98.5M	102.4M
Cost Of Revenue	295.4M	341.5M	380.3M	370M	290.6M	531.1M
Total Operating Expenses	457.9M	419.4M	355.4M	376M	330.3M	320.7M
Income Before Tax	(64M)	(60.5M)	5.8M	65.2M	(7.9M)	(7.5M)
Total Other Income Expense Net	(8.3M)	(14.4M)	(3.1M)	(8.8M)	(60.3M)	(63.3M)
Net Income	(45.9M)	(27.2M)	6.3M	50.5M	(61.8M)	(58.7M)
Income Tax Expense	(18.1M)	(33.3M)	600K	14.7M	2M	1.9M
Net Income Applicable To Common Shares	(45.9M)	(27.2M)	5.2M	50.5M	45.5M	47.7M
Net Income From Continuing Ops	(82.1M)	(27.2M)	5.2M	50.5M	(9.9M)	(10.4M)
Non Operating Income Net Other	7.8M	6.7M	1.2M	200K	1.1M	2.1M
Tax Provision	(18.1M)	(33.3M)	600K	14.7M	2M	2.1M
Interest Income	7.8M	6.7M	1.2M	200K	2.9M	5.0M
Net Interest Income	(8.3M)	(14.4M)	(3.1M)	(8.8M)	(12.1M)	(12.7M)
Reconciled Depreciation	36.9M	42.9M	38.3M	47.7M	46.1M	34.8M

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Avanos Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Avanos Medical's short interest history, or implied volatility extrapolated from Avanos Medical options trading.

Pair Trading with Avanos Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Avanos Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avanos Medical will appreciate offsetting losses from the drop in the long position's value.

Moving together with Avanos Stock

0.62

CVS

CVS Health Corp Sell-off Trend

Pair Corr

Moving against Avanos Stock

0.48

DYNT

Dynatronics Financial Report 9th of May 2024

Pair Corr

The ability to find closely correlated positions to Avanos Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Avanos Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Avanos Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Avanos Medical to buy it.

The correlation of Avanos Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Avanos Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Avanos Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Avanos Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Avanos Medical is a strong investment it is important to analyze Avanos Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avanos Medical's future performance. For an informed investment choice regarding Avanos Stock, refer to the following important reports:

How To Invest In Avanos

Details

Is Avanos Stock a good investment?

Details

What is Avanos Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.

You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Avanos Stock analysis

When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.

	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities

Is Avanos Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avanos Medical. If investors know Avanos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avanos Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.38)

Earnings Share

(0.21)

Revenue Per Share

14.448

Quarterly Revenue Growth

(0.05)

Return On Assets

0.0164

The market value of Avanos Medical is measured differently than its book value, which is the value of Avanos that is recorded on the company's balance sheet. Investors also form their own opinion of Avanos Medical's value that differs from its market value or its book value, called intrinsic value, which is Avanos Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avanos Medical's market value can be influenced by many factors that don't directly affect Avanos Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Avanos Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avanos Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avanos Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Avanos Historical Income Statement

About Avanos Income Statement Analysis

Avanos Medical Income Statement Chart

Interest Expense

Total Revenue

Gross Profit

Other Operating Expenses

Avanos Medical income statement Correlations

Avanos Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Avanos Medical income statement Accounts

Pair Trading with Avanos Medical

Moving together with Avanos Stock

Moving against Avanos Stock

Complementary Tools for Avanos Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cost Of Revenue	+ 1.0	Total Revenue
Income Before Tax	+ 1.0	Operating Income
Extraordinary Items	+ 1.0	Discontinued Operations
Selling And Marketing Expenses	+ 1.0	Non Recurring
Other Operating Expenses	+ 0.99	Total Revenue
Cost Of Revenue	+ 0.99	Other Operating Expenses

Extraordinary Items	- 0.99	Interest Income
Interest Income	- 0.99	Discontinued Operations
Interest Income	- 0.9	Tax Provision
Reconciled Depreciation	- 0.87	Net Interest Income
Extraordinary Items	- 0.87	Income Tax Expense
Discontinued Operations	- 0.86	Income Tax Expense